Once-daily dose of glaucoma drug omidenepag isopropyl offers similar benefit as two doses

A once-daily dose of the novel drug omidenepag isopropyl showed the same efficacy as twice-daily dosing and was more tolerable for patients.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553